Guidance Capital, Inc Bristol Myers Squibb CO Transaction History

Guidance Capital, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $69,793 - $91,884	-1,734 Reduced 17.45%	8,205 $390 Million
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $39,103 - $44,336	-815 Reduced 7.58%	9,939 $482 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $75,580 - $90,188	1,559 Added 16.95%	10,754 $567 Million
Q3 2023 Oct 16, 2023	BUY	$57.89 - $64.73 $1,215 - $1,359	21 Added 0.23%	9,195 $526 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $584,475 - $648,968	9,174 New	9,174 $562 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Guidance Capital, Inc, based on Form 13F filings with the SEC.

Stay updated on Guidance Capital, Inc with notifications on news.